Send mail to Author

Randomized trial of the efficacy and safety of Berotralstat (BCX7353) as an oral prophylactic therapy for hereditary angioedema: results of APeX-2 ihrough 48 weeks (Part 2) (Article)

Please indicate your contact information and select, which author you want to contact.



 
  _  __   __   __   _____       ___      _  _    _    _   
 | |/ //  \ \\/ // |  __ \\    / _ \\   | \| || | || | || 
 | ' //    \ ` //  | |  \ ||  / //\ \\  |  ' || | || | || 
 | . \\     | ||   | |__/ || |  ___  || | .  || | \\_/ || 
 |_|\_\\    |_||   |_____//  |_||  |_|| |_|\_||  \____//  
 `-` --`    `-`'    -----`   `-`   `-`  `-` -`    `---`   
                                                          
 


Back to frontdoor view